Cystic fibrosis (CF) arises from the mutation of a single gene encoding the cystic fibrosis
transmembrane conductance regulator (CFTR), 1 a chloride channel that is widely …

Since the onset of the coronavirus disease, COVID-19 pandemic, concern arose for those
who might be at higher risk of a worse COVID-19 prognosis, such as those with cystic …

Purpose To describe the clinical course of COVID-19 in patients with cystic fibrosis (CF) and
to identify risk factors for severe COVID-19. Methods We conducted a prospective study …

Study objective Intravenous thrombolysis with alteplase has been the foundation of initial
treatment of acute ischemic stroke for several decades. Tenecteplase is a thrombolytic agent …

Improving standards of care and new therapeutics means individuals with cystic fibrosis are
living longer, but this brings an increased risk of non-communicable diseases, especially …

Background There have been reports and studies indicating audiovestibular disturbances in
COVID-19 patients with variations in the percentage of sensorineural hearing loss (SNHL) …

Background: The impact of COVID-19 on respiratory outcomes in people with cystic fibrosis
(pwCF) has not been clearly characterized. We evaluated changes in respiratory function …

A long-shared evolutionary history is congruent with the multiple roles played by purinergic
signaling in viral infection, replication and host responses that can assist or hinder viral …

Background Celiac disease (CD) is associated with an increased risk for respiratory
infections and severe outcomes. No data have been reported in the scientific literature …

Cystic fibrosis (CF) is a genetic ailment caused by mutations in the cystic fibrosis
transmembrane conductance regulator (CFTR) gene. This autosomal recessive disorder is …